|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,960.50 GBX | +1.24% |
|
+1.50% | +7.45% |
| 08-06 | LifeMine Therapeutics, Inc. announced that it has received $188 million in funding from a group of investors | CI |
| 08-06 | US FDA approves first mRNA flu shot from Moderna | RE |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Bullish |
| Resistance | 2,029 | 2,268 | 2,213 |
| Spread/Res. | -3.38% | -13.56% | -11.41% |
| Spread/Supp. | +4.17% | +7.69% | +8.86% |
| Support | 1,882 | 1,820.5 | 1,801 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- GSK Stock
- Charts GSK plc
Select your edition
All financial news and data tailored to specific country editions
